March 19th 2024
The latest news for pharma industry insiders.
Hurdles Hindering the Translation of AI-Powered Research into Tangible Clinical Benefits
March 15th 2024In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses why no novel active substances have yet been brought to market through AI technology despite increasing investments in the space for drug discovery as shown in IQVIA's Global Trends in R&D 2024 report.
Navigating the CBD Research Landscape: Unveiling Best Practices in the Post-MMCREA Era
Although research on cannabinoids is now allowed in a growing number of countries, there are still a number of restrictions and corresponding licenses and permits required to work with these chemicals.
Benefits and Limitations of Strategies Used to Improve Clinical Development Productivity
March 13th 2024In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses findings from IQVIA's Global Trends in R&D 2024 report including the potential benefits and limitations of novel trial designs and decentralized methodologies.
Industry Business Check: Market Review Rates the Latest Full-Year Outputs
A look at pharma and biotech financing, M&A, and stock market performance in 2023—and where developments may head next as company executives continue to navigate stormy but perhaps stabilizing waters in the months ahead.